These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38553612)

  • 1. YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.
    Li S; Li X; Yang YB; Wu SF
    Apoptosis; 2024 Mar; ():. PubMed ID: 38553612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of YAP/TAZ-TEAD activity induces cytotrophoblast differentiation into syncytiotrophoblast in human trophoblast.
    Mizutani T; Orisaka M; Miyazaki Y; Morichika R; Uesaka M; Miyamoto K; Yoshida Y
    Mol Hum Reprod; 2022 Sep; 28(10):. PubMed ID: 35993908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the YAP/TAZ-TEAD Transcriptional Complex in the Metabolic Control of TRAIL Sensitivity by the Mevalonate Pathway in Cancer Cells.
    El Yousfi Y; Mora-Molina R; López-Rivas A; Yerbes R
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review.
    Crawford JJ; Bronner SM; Zbieg JR
    Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112
    [No Abstract]   [Full Text] [Related]  

  • 6. HIF-1
    Abudoukerimu A; Hasimu A; Abudoukerimu A; Tuerxuntuoheti G; Huang Y; Wei J; Yu T; Ma H; Yimiti D
    J Oncol; 2022; 2022():3814809. PubMed ID: 35664561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.
    He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K
    Elife; 2021 Aug; 10():. PubMed ID: 34463254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanosignaling YAP/TAZ-TEAD Axis Regulates the Immunomodulatory Properties of Mesenchymal Stem Cells.
    Yoshii H; Kajiya M; Yoshino M; Morimoto S; Horikoshi S; Tari M; Motoike S; Iwata T; Ouhara K; Ando T; Yoshimoto T; Shintani T; Mizuno N
    Stem Cell Rev Rep; 2024 Jan; 20(1):347-361. PubMed ID: 37917410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
    Sturbaut M; Bailly F; Coevoet M; Sileo P; Pugniere M; Liberelle M; Magnez R; Thuru X; Chartier-Harlin MC; Melnyk P; Gelin M; Allemand F; Guichou JF; Cotelle P
    Eur J Med Chem; 2021 Dec; 226():113835. PubMed ID: 34509860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner.
    Han D; Byun SH; Park S; Kim J; Kim I; Ha S; Kwon M; Yoon K
    Biochem Biophys Res Commun; 2015 Feb; 458(1):110-6. PubMed ID: 25634692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of YAP/TAZ, TEAD and TP63 activity is associated with bronchial premalignant severity and progression.
    Ning B; Tilston-Lunel AM; Simonetti J; Hicks-Berthet J; Matschulat A; Pfefferkorn R; Spira A; Edwards M; Mazzilli S; Lenburg ME; Beane JE; Varelas X
    J Exp Clin Cancer Res; 2023 May; 42(1):116. PubMed ID: 37150829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP/TAZ-TEAD is a novel transcriptional regulator of genes encoding steroidogenic enzymes in rat granulosa cells and KGN cells.
    Mizutani T; Orisaka M; Kawabe S; Morichika R; Uesaka M; Yoshida Y
    Mol Cell Endocrinol; 2023 Jan; 559():111808. PubMed ID: 36309205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library.
    Lauriola A; Uliassi E; Santucci M; Bolognesi ML; Mor M; Scalvini L; Elisi GM; Gozzi G; Tagliazucchi L; Marverti G; Ferrari S; Losi L; D'Arca D; Costi MP
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present).
    Zagiel B; Melnyk P; Cotelle P
    Expert Opin Ther Pat; 2022 Aug; 32(8):899-912. PubMed ID: 35768160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VASN promotes proliferation of laryngeal cancer cells via YAP/TAZ.
    Liu H; Kong W; Wen S; Wu J; Yin X; Liu Y
    J BUON; 2021; 26(4):1563-1570. PubMed ID: 34565020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
    Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
    Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
    Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N
    J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
    Miesfeld JB; Link BA
    Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
    Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
    Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.